Inspira Technologies has successfully completed the regulatory submission of its FDA-cleared INSPIRA ART100 system to the United Arab Emirates Ministry of Health and Prevention. Final approval is expected soon, signaling a major step towards entering the Gulf region’s healthcare market. The company anticipates rapid commercial expansion following authorization, leveraging the UAE’s efficient regulatory framework. Inspira Technologies specializes in advanced respiratory support and blood monitoring solutions, positioning itself as a key player in the global MedTech landscape. The company’s strategic partnerships and innovative products are set to revolutionize healthcare in the Middle East.

Read more at GlobeNewswire: Inspira Technologies Nears Final Regulatory Clearance for